GlobalData
GlobalData

Business Fundamentals

APAC deal activity down by 42.2% YoY in February 2023, finds GlobalData

The Asia-Pacific (APAC) region is a critical market for global deal-making, with significant investments and mergers taking place across various industries. However, deal activity in the APAC region has seen a significant decline of 42.2% year-over-year (YoY) in February 2023, reveals GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database […]
Read more

GlobalData forecasts Argentina economy to stagnate in 2023

Argentina is facing the challenge of rising inflation and high interest rates, which are likely to decrease household disposable incomes and hinder private consumption. Moreover, the country’s economic activity may be limited due to high debt levels, strict import regulations, and low foreign reserves, as the Argentine peso is expected to depreciate significantly. As a […]
Read more

Travel and tourism industry deal activity sinks by 60.4% YoY in February 2023, reveals GlobalData

The global travel and tourism industry, which has been struggling to rebound from the COVID-19 pandemic induced slowdown, is facing another setback with a significant drop in deal activity. The industry, which relies heavily on investment and strategic partnerships, saw a steep year-on-year (YoY) 60.4% decline in deal activity in February 2023, reveals GlobalData, a […]
Read more

Companies explore M&A opportunities to navigate volatile market conditions, finds GlobalData

Despite the ongoing volatile market conditions and the challenges posed by inflation, companies are actively discussing about mergers and acquisitions (M&A). Companies are looking to leverage M&A opportunities to enhance their market position, gain access to new technologies and markets, and remain competitive in today’s dynamic business landscape, reveals the study of companies’ annual reports […]
Read more

Global deal activity plummets by 43.1% YoY in February 2023, reveals GlobalData

Global deal activity across all regions and types suffered a massive 43.1% decline in February 2023 as venture capital investors grapple with the uncertain geopolitical tensions, lower GDP growth, inflation, and rising interest rates, according to GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database reveals that global deal volume […]
Read more

Artificial intelligence startups raise over $50 billion venture capital funding in 2022, reveals GlobalData

The rapid advancement of artificial intelligence (AI) has captured the attention of venture capital (VC) investors globally. Against this backdrop, 3,198 AI startups received $52.1 billion funding across 3,396 VC funding deals during 2022, reveals GlobalData, a leading data and analytics company. However, an analysis of GlobalData’s Financial Deals Database reveals that 2022 experienced a […]
Read more

Challenging market conditions fail to deter companies from discussing about investment around R&D, new technologies, reveals GlobalData

Amid the ongoing volatile market conditions, companies continue to engage in discussions surrounding potential investments. Despite the challenges posed by inflation, companies remain focused on driving innovation and growth in their respective industries, reveals the study of companies’ annual reports and earnings call transcripts by GlobalData, the leading data and analytics company. GlobalData’s latest report, […]
Read more

Fall of Silicon Valley Bank, Signature Bank, and Silvergate Capital could invite trouble for few more US banks, says GlobalData

Following the collapse of tech-focused US banks such as Silicon Valley Bank, Signature Bank, and Silvergate Capital Corp; Murthy Grandhi, Analyst at GlobalData, a leading data and analytics company, offers his view: “Over the last week, the US banking stocks plummeted following the crisis engulfing Silicon Valley Bank. Collectively, the US banks lost over $267 […]
Read more

APAC biotech companies lag US counterparts in venture funding for innovator drugs, finds GlobalData

Venture financing for early-stage innovator drugs by biotech companies headquartered in Asia-Pacific (APAC) and the US increased from 2020 to 2021. However, the APAC biotech companies received three times less investments than their US counterparts between 2018 and 2022, reveals GlobalData, a leading data and analytics company. According to GlobalData’s Pharma Intelligence Center Deals database, […]
Read more

GlobalData company filings report shows dwindling business sentiment, escalating macroeconomic risks in 2022

Inflation, Slowdown, Recession, Shortages, Supply Chain dominated discussions Ukraine among key countries discussed amidst geopolitical tensions Aerospace & Defense, and Insurance industry sentiment positive Carbon Capture & Storage, Metaverse and Cryptocurrencies trending themes The year 2022 brought about a significant shift in the sentiment of businesses as they navigated through a challenging economic landscape. There […]
Read more
1 61 62 63 64 65 133